Two in three adults could be obese by 2050, according to world heart report (EMB Sat 17th 00:00)
Two in three adults over the age of 25 could be obese or overweight by 2050, experts have warned.
Access to healthy and affordable food, green spaces and a shift towards desk jobs and longer working hours have contributed to increasing levels of obesity, according to the newly released World Heart Report.
The report, compiled by the World Heart Foundation, also highlights that 'game changing' medical interventions such as weight loss jabs like Wegovy, are showing positive steps.
Globally the number of adults living with obesity has quadrupled since 1990 from 194 million to 878 million in 2022 – a figure that is only expected to rise.
Obesity is known to significantly increase the risk of several health conditions including heart disease, type 2 diabetes, stroke and some cancers, according to the NHS.
It causes 3.7 million deaths per year and is a leading driver of deaths from cardiovascular disease, the report by the World Heart Federation warns.
High BMI accounts for nearly 10 per cent of all cardiovascular deaths worldwide, doubling to 1.9 million in three decades.
Children with a high BMI are 40 per cent more likely than those with low BMI to suffer with cardiovascular disease in midlife.
The economic impact of obesity is also rising. Costs to the global economy from obesity-related healthcare needs, productivity losses and death are estimated to amount to 2.2 per cent of global Gross Domestic Product (GDP).
That's just under $2 trillion per year and it could reach 3 per cent annually by 2060.
To tackle the problem some countries including the UK, Japan and Rwanda have taken steps to tackle obesity by limiting the density of fast-food outlets, particularly near schools and areas with childhood obesity and deprivation.
The report also highlights that 'game changing' medical interventions such as weight loss jabs like Wegovy, are showing positive steps.
'To address the growing implications of the obesity crisis, we urge action and targeted investment by governments around the world. Health systems must be strengthened to ensure broader access to, and affordability of, medical care for obesity and cardiovascular disease,' said Mariachiara Di Cesare, Professor of Population Studies and Global Health, and Director of the Institute of Public Health and Wellbeing at the University of Essex, and one of the report authors.
The report also suggests some health professionals hold negative biases about obesity and to view patients as 'non-compliant with health advice'.
It explains this can deter people with obesity from seeking medical care, including prevention and screening, putting their overall health at risk.
Authors also highlight that the perception that people living with obesity are 'lazy, gluttonous, and lacking in self-discipline" has long lasting psychological and physical consequences.
Children and young adults are especially vulnerable to bullying and discrimination based on their weight, and obesity is now the leading cause of such bullying in schools, affecting children's education and their mental health.
'Longstanding weight stigma and discrimination have hindered efforts to tackle obesity and contributed to the rise of CVDs, so it is urgent to address both,' Professor of Medicine at Mayo Clinic College of Medicine and one of the report authors said.
'Any policy to tackle obesity must address health disparities and support underserved populations who face greater barriers to healthy living and obesity therapies, while taking care to not further entrench the stigmatisation of obesity,' he added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
25 minutes ago
- Washington Post
Hurdles to GLP-1s threaten the lives of our patients
The May 26 front-page article 'Patients face new hurdles to affordable obesity drugs' highlighted significant barriers patients and providers face in accessing GLP-1 and dual GLP-1/GIP receptor agonists (such as Ozempic, Mounjaro, Wegovy, Tirzepatide and Zepbound) for weight management. However, one critical group whose lives may depend on these medications was absent: individuals with end-stage organ failure. For these patients, the path to a lifesaving transplant is often long and uncertain. Many wait years on transplant lists — if they can get on one at all. Obesity is a major obstacle in this process. It not only reduces the likelihood of being listed for transplantation but also increases the risk of poor outcomes posttransplant, including higher rates of failure of their transplanted organ, wound complications, heart disease and diabetes. GLP-1 medications have demonstrated benefits beyond weight loss, including reducing the risk of heart disease and slowing the progression of kidney disease in certain populations. These benefits could improve both pre- and posttransplant outcomes, offering a critical bridge to transplantation and enhancing long-term survival. Yet access to these medications is increasingly limited. Many insurance companies have removed them from the lists of drugs that they cover, restricted the duration of use, or required patients to try other, often inappropriate, treatments first and show they aren't working. For people with organ failure, particularly those with kidney disease, there are few to no safe and effective alternatives. This leaves a growing number of patients unable to access the only medications that might improve their transplant eligibility. Medicare provides indefinite coverage for dialysis — a life-sustaining but extremely costly intervention — yet does not cover GLP-1 medications prescribed for weight loss that could help patients lose enough weight to become eligible for a kidney transplant, ultimately reducing or even eliminating the need for dialysis. Expanding access to these therapies for individuals with end-stage organ failure is not only an issue of equity and compassion — it is also a sound fiscal strategy. By improving transplant eligibility and outcomes, we can reduce long-term dependence on dialysis, resulting in substantial cost savings for Medicare and other health-care payers. Though cash payment options exist, the out-of-pocket cost — often several hundred dollars per month — is simply unaffordable for many patients. This financial barrier exacerbates existing disparities and deepens inequities in access to transplant care. Focusing on patients with organ failure presents a clear opportunity to save lives and reduce health-care costs. We urge policymakers and drug manufacturers to prioritize this narrow but critically important population by lowering the cost and improving access to GLP-1 medications. For these individuals, access is about survival. Sima Saberi, Ann Arbor, Michigan Vineeta Kumar, Birmingham, Alabama Mohammad Kazem Fallahzadeh, Winston Salem, North Carolina Krista Lentine, St. Louis Hector Madariaga, Cambridge, Massachusetts Pooja Budhiraja, Phoenix Vasanthi Balaraman, Memphis Prince Mohan Anand, Lancaster, South Carolina Kenneth J. Woodside, Charleston, South Carolina Sabiha M. Hussain, Philadelphia The writers are physicians who provide care for people with organ transplants. The May 30 online Fact Checker analysis, 'Are 4.8 million people on Medicaid 'cheating the system,'' cut to the heart of a growing crisis: the way data is being twisted to justify cruelty, particularly against people like me. I'm autistic, and I've had to rely on Medicaid — not because I don't want to work, but because I live in a society that doesn't always make room for people like me to thrive, or even survive, on its terms. I've spent much of my adult life navigating a system that treats vulnerability as a burden and not as a fact of human existence. That's why I was so disturbed by Sen. Joni Ernst's (R-Iowa) response at a recent town hall, when a constituent in Butler County warned that proposed budget cuts under President Donald Trump's administration would lead people to die. Ernst smiled and replied, 'Well, we are all going to die.' That smile and her dismissive wave of the hand might have been the product of awkwardness. But indifference to injustice can be deeply damaging. Ernst wasn't denying that deaths would happen. She was suggesting they don't really matter because death comes for us all. There's a chilling difference between acknowledging mortality and brushing off preventable deaths as unimportant. When our leaders fail to take the lives of their most vulnerable constituents seriously, it sends a message: that those lives have no place in their political calculations. That we are disposable. The Post's Fact Checker analysis showed that the 4.8 million figure cited by House Speaker Mike Johnson (R-Louisiana) was a projection of people who would lose Medicaid insurance if the House bill became law. The people being painted as 'cheaters' are often the sick, disabled, elderly or those caring for others full-time. They are people whose work might not fit into conventional molds, but whose lives and contributions matter deeply. Ernst's comment might have sounded like a joke to some. To me, as someone who knows how fragile survival can be, it sounded like a warning. A government that makes light of your death is not a government that's protecting your life. Matthew Lovewell, Pittsburgh We are facing a crisis in coverage for obesity care, leaving countless Americans struggling to access treatment for this chronic disease. As highlighted by the May 26 front-page article 'Patients face new hurdles to affordable obesity drugs,' the lack of obesity care coverage for GLP-1 medications not only strains an inundated health-care system and its overwhelmed providers, but also has a significant human and financial cost for patients, insurers and employers. The status quo must change. Despite obesity being recognized as a chronic, treatable disease that is associated with more than 200 other health conditions, insurers continue to place barriers on coverage for obesity care. Furthermore, the Centers for Medicare & Medicaid Services' recent decision not to expand coverage of obesity management medications through Medicare and Medicaid underscored the ongoing struggle individuals living with obesity face in accessing care. The costs of not treating obesity are staggering. Collectively, diseases linked to obesity cost our nation's health-care system more than $1.7 trillion each year. Additionally, obesity costs employers approximately $425 billion annually in the form of increased medical costs, disability payments, workers' compensation programs and absenteeism. Providing coverage for the full range of evidence-based care is crucial in addressing the significant consequences of obesity. Patients should be able to work with their health-care provider to decide on the best evidence-based obesity treatment — and have insurance coverage for that care. We must all call on insurers, employers and policymakers to ensure comprehensive obesity care is covered just like any other chronic disease — it's only fair. Millicent Gorham, Washington The writer is CEO of the Alliance for Women's Health and Prevention. Regarding the May 28 front-page article 'RFK Jr. remolds policy on covid': Although the coronavirus vaccines for children and adults are safe and effective, the Food and Drug Administration removed them from its recommended immunization schedule for healthy children and pregnant women. This is incredibly irresponsible. Children play a significant role in the transmission of the coronavirus. During the pandemic, more than 70 percent of household coronavirus transmissions originated with a child, and data shows that young children can be considerable transmission vectors within households, despite having lower viral loads. Many infected children are asymptomatic, making it harder to identify and control the spread. This means children who might be infected but do not show symptoms can transmit the virus to others. It is true that most children generally present with mild disease and exhibit lower hospitalization rates than adults. However, infected children can experience long covid and its long-term effects, including fatigue and muscle weakness. Pregnant women also face a higher risk of developing severe coronavirus complications compared with nonpregnant individuals. Without vaccination, they are more likely to require intensive care and mechanical ventilation, are at a higher risk of mortality and severe illness, and are four times more likely to be hospitalized than vaccinated pregnant women. Coronavirus infection during pregnancy can lead to serious complications, including a higher risk of preterm birth, an increased likelihood of developing preeclampsia and a greater chance of gestational diabetes. And a mother vaccinated against the coronavirus can transfer protective antibodies to the fetus, providing immunity to the newborn after birth. The benefits of coronavirus immunization far outweigh any potential risks, establishing it as a vital preventive measure for children and all pregnant women. It is irresponsible not to recommend and support its use. A.J. Russo, Chincoteague, Virginia The writer is author of 'Vaccine Development and the Understanding of Immunity.' I am a doctor, and I spent the majority of my career as executive director of the Pasco County Health Department in Florida. Limiting access to the coronavirus vaccine conflicts with recommended public health policy. Denying and discouraging lifesaving vaccines to at-risk groups will increase the rates of death and disability caused by this serious disease. Political interference with recommended public health policy concerning this disease has already taken a terrible toll on Americans. Yet politicians turn a blind eye to their responsibility bucking professional and expert guidance from the New England Journal of Medicine and the Centers for Disease Control and Prevention. Those who allowed this disease to race through the American population should be held accountable, not shielded. Now again, an untrained and questionably informed bureaucrat, wants to compromise protections for millions of Americans who should be getting the vaccine. I believe the Food and Drug Administration's changes to its approval process for the coronavirus vaccine has a serious potential to allow this disease to race out of control again. I continue to have full confidence in the recommendations made by professional public health scientists and doctors. When government agencies choose to blind themselves to studies and recommendations, we all pay a terrible price. Marc J. Yacht, Hudson, Florida
Yahoo
35 minutes ago
- Yahoo
Report accuses NHS health trust of 'nepotism'
A report has uncovered allegations of nepotism and inequality at an NHS mental health trust. The study - led by former NHS equality director Yvonne Coghill - was based on the experiences of 100 members of staff at the Norfolk and Suffolk NHS Foundation Trust (NSFT) and was commissioned by NSFT itself. Findings included evidence that the disciplinary processes for staff from a black, Asian and minority ethnic background (BAME) were "more draconian". Dr Faisil Sethi, NSFT's deputy chief executive, said: "While we have made some progress, we have much more to do to reduce disparity of experience and improve the lives of our colleagues from black and minority ethnic backgrounds." The workforce race equality report found staff felt there were significant discrepancies in recruitment, career progression, the disciplinary process and equal opportunities. It included allegations of "widespread and problematic nepotism" and a fear of speaking up or making complaints. Some staff felt there was no clear process for dealing with racist patients. In the report, NSFT's leadership was accused of not understanding race, and senior leaders were accused of not listening. In the report, Caroline Donovan, NSFT chief executive, said it was her aim to ensure everyone "regardless of background has the best possible experience of working here". She added: "NSFT, similar to many organisations, has challenges of racial disparity which need urgent and sustaining leadership." The report recommended NSFT held a conference about the findings, and conducted an audit of its application process. It said all board members must have a clear and deep understanding of the issues and leaders must listen to BAME staff and commit to being anti-racist. Dr Sethi added that race discrimination was taken "extremely seriously" at NSFT. He said the report was part of the trust's commitment to embrace "cultural diversity and racial equality". Follow Norfolk news on BBC Sounds, Facebook, Instagram and X. Mental health a 'high priority' says government 'Worst' mental health trust shows improvement Norfolk and Suffolk NHS Foundation Trust
Yahoo
2 hours ago
- Yahoo
Warning over measles risk during school holidays
Parents are being urged to make sure their children are vaccinated against measles ahead of the summer holidays as an outbreak continues to spread across the UK. Measles is one of the most contagious diseases in the world, but two doses of the MMR vaccine during childhood can offer lifelong protection. However, uptake of the vaccine in Britain is below recommended levels, and cases have been rising. Young children have the first dose of the vaccine when they are one year old and the second at between three years and four months and five years of age. There have been 420 measles cases in England so far this year, with 86 last month alone, figures from the UK Health Security Agency (UKHSA) reveal. Two thirds of the cases were in children under 10, and almost 40 per cent were in London. The capital has the lowest vaccination percentage in the country, with more than a quarter of the population going without full protection. Officials are concerned that the infection, which can lead to serious complications, spreads easily through the air via sneezes, coughs and exhalations. They said it could see an uptick when schools break up for the summer and children mingle during the holidays. Measles has an estimated 'R' number of around 18, which means that, on average, a single infected person passes the infection on to 18 others. Covid has a natural 'R' number of about three. Dr Vanessa Saliba, a consultant epidemiologist at UKHSA, said: 'It's essential that everyone, particularly parents of young children, check all family members are up to date with two MMR doses, especially if you are travelling this summer for holidays or visiting family. 'Measles cases are picking up again in England, and outbreaks are happening in Europe and many countries with close links to the UK. 'Measles spreads very easily and can be a nasty disease, leading to complications like ear and chest infections and inflammation of the brain, with some children tragically ending up in hospital and suffering life-long consequences. Nobody wants this for their child, and it's not something you want to experience when away on holiday.' People who have the two doses of the MMR vaccine, which are safe and effective, are not only protecting themselves but also helping protect others who are unvaccinated, such as young babies. Health officials said parents could check their child's 'red book', a national record given to parents or carers to document a child's health and development, to see if they are fully protected. Adults can check their vaccination status by contacting their GP or checking in the NHS app, although not everyone's complete immunisation data is live on the app. UKHSA said that cases in Europe had reached their highest level in almost three decades last year. A global increase in measles has led the agency to say it is concerned that this could mean people bring back the contagious disease to England after travelling over the summer. There were more than 127,000 cases of measles in Europe last year, according to global health leaders, the highest number since 1997. So far this year, outbreaks have been documented in France, Italy, Spain and Germany. Romania, Pakistan, India, Thailand, Indonesia and Nigeria currently have among the largest number of measles cases worldwide, according to a recent report by the World Health Organisation. Dr Amanda Doyle, the national director for primary care and community services at NHS England, said: 'The recent increase in cases seen in England and Europe should act as an important reminder to ensure your child is protected. 'Too many babies and young children are still not protected against the diseases, which are contagious infections that spread very easily and can cause serious health problems. 'MMR jabs are provided free as part of the NHS routine immunisation programme, and I would encourage all parents to act on invites or check vaccination records if they think they may have missed their child's vaccination.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
